Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROphylaxis for paTiEnts at risk of COVID-19 infecTion (PROTECT)
2020-004144-28Phase 2Unknown
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Nasal niclosamide with Placebo (2 arms). Primary endpoint: Time to confirmed symptomatic COVID-19 infection. Status: unknown.
02
Drugs
niclosamide
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-004144-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-004144-28.